Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs BAFNA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES BAFNA PHARMA SUVEN LIFE SCIENCES/
BAFNA PHARMA
 
P/E (TTM) x -20.5 16.1 - View Chart
P/BV x 5.8 2.5 234.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 SUVEN LIFE SCIENCES   BAFNA PHARMA
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-23
BAFNA PHARMA
Mar-23
SUVEN LIFE SCIENCES/
BAFNA PHARMA
5-Yr Chart
Click to enlarge
High Rs94141 66.5%   
Low Rs4579 57.3%   
Sales per share (Unadj.) Rs0.648.8 1.3%  
Earnings per share (Unadj.) Rs-5.44.8 -113.2%  
Cash flow per share (Unadj.) Rs-5.17.0 -72.7%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs17.231.0 55.4%  
Shares outstanding (eoy) m218.0723.66 921.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x111.82.3 4,965.0%   
Avg P/E ratio x-12.822.9 -55.9%  
P/CF ratio (eoy) x-13.515.6 -87.0%  
Price / Book Value ratio x4.03.5 114.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m15,1312,596 582.8%   
No. of employees `000NANA-   
Total wages/salary Rs m186159 117.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1351,154 11.7%  
Other income Rs m8433 258.1%   
Total revenues Rs m2201,186 18.5%   
Gross profit Rs m-1,196157 -761.2%  
Depreciation Rs m6553 122.7%   
Interest Rs m520 26.4%   
Profit before tax Rs m-1,183116 -1,018.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m03 0.0%   
Profit after tax Rs m-1,183113 -1,043.1%  
Gross profit margin %-883.613.6 -6,485.8%  
Effective tax rate %02.4 -0.0%   
Net profit margin %-873.59.8 -8,887.1%  
BALANCE SHEET DATA
Current assets Rs m3,455873 395.7%   
Current liabilities Rs m1,050465 226.0%   
Net working cap to sales %1,776.035.4 5,016.9%  
Current ratio x3.31.9 175.1%  
Inventory Days Days3,9482 230,291.5%  
Debtors Days Days2181,302 16.7%  
Net fixed assets Rs m1,373423 324.9%   
Share capital Rs m218237 92.2%   
"Free" reserves Rs m3,535498 709.9%   
Net worth Rs m3,753735 511.0%   
Long term debt Rs m084 0.0%   
Total assets Rs m4,8281,296 372.6%  
Interest coverage x-218.86.7 -3,266.2%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x00.9 3.2%   
Return on assets %-24.410.3 -236.2%  
Return on equity %-31.515.4 -204.2%  
Return on capital %-31.416.7 -188.1%  
Exports to sales %40.40-   
Imports to sales %839.87.9 10,690.9%   
Exports (fob) Rs m55NA-   
Imports (cif) Rs m1,13791 1,254.9%   
Fx inflow Rs m55885 6.2%   
Fx outflow Rs m1,13791 1,254.9%   
Net fx Rs m-1,082794 -136.2%   
CASH FLOW
From Operations Rs m-1,03150 -2,082.5%  
From Investments Rs m-2,606-75 3,478.5%  
From Financial Activity Rs m3,955102 3,886.6%  
Net Cashflow Rs m31776 415.7%  

Share Holding

Indian Promoters % 69.6 88.4 78.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 0.0 -  
FIIs % 0.5 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 11.6 263.0%  
Shareholders   74,003 7,367 1,004.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Suven Life Sciences vs BAFNA PHARM.

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Suven Life Sciences vs BAFNA PHARM. Share Price Performance

Period Suven Life Sciences BAFNA PHARM. S&P BSE HEALTHCARE
1-Day 0.30% -1.07% 1.18%
1-Month -2.06% -11.71% -0.75%
1-Year 114.92% -4.18% 61.82%
3-Year CAGR 14.94% -19.05% 18.16%
5-Year CAGR -16.22% 47.58% 19.79%

* Compound Annual Growth Rate

Here are more details on the Suven Life Sciences share price and the BAFNA PHARM. share price.

Moving on to shareholding structures...

The promoters of Suven Life Sciences hold a 69.6% stake in the company. In case of BAFNA PHARM. the stake stands at 88.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Suven Life Sciences and the shareholding pattern of BAFNA PHARM..

Finally, a word on dividends...

In the most recent financial year, Suven Life Sciences paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

BAFNA PHARM. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Suven Life Sciences, and the dividend history of BAFNA PHARM..

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.